Clinical characteristics and transabdominal ultrasound features that associated with T3-T4 staging in gastric cancer: A retrospective study

Table 2 Univariate analysis of influence factors between pathological T1-T2 staging and T3-T4 staging

Variable	T3-T4 staging (n = 92)	T1-T2 staging (n = 21)	t/χ2	P value
Age (years)	58.4 ± 12.2	57.7 ± 10.9	-0.250	0.803
BMI (kg/m2)	21.4 ± 3.2	20.1 ± 2.9	-1.862	0.065
Gender
Male/female	61/31	10/11	2.556	0.110
Lesion thickness (cm)	1.6 ± 0.6	1.0 ± 0.4	-4.022	< 0.001
Lesion length (cm)	5.7 ± 2.2	2.9 ± 1.0	-5.596	< 0.001
Presence of angle sign
Yes/no	85/7	4/17	50.684	< 0.001
Presence of ulcer
Yes/no	52/40	11/10	0.119	0.730
Lesion location
Gastric antrum	44	9	7.740	0.102
Gastric fundus	9	3
Gastric body	30	3
Gastric fundus + body	6	5
Gastric angle	3	1
CEA	58/34	21/0		< 0.001
< 5 μg/L/≥ 5 μg/L
CA19-9	67/25	18/3	0.911	0.034
< 37 kU/L/≥ 37 kU/L
Clinical feature
Epigastrium discomfort or dull pain	29	7		0.758
Abdominal pain with black stool	15	3
Abdominal pain with belching	17	5
Abdominal distension with anorexia	15	2
Abdominal pain with vomiting	13	2
Dysphagia	3	2
Histologic type
Poor differentiated	60	11	2.190	0.335
Moderate differentiated	29	8
Well differentiated	3	2
Lauren type
Diffuse type	60	10	2.579	0.275
Hybrid type	12	3
Intestinal type	20	8

BMI: Body mass index; CEA: Carcinoembryonic antigen.